Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
Clinical trial NCT06070961 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06070961
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-07
- Primary completion
- 2027-05-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.